APA (7th ed.) Citation

O, F., S, B., K, F., AG, d. L., W, F., T, K., . . . M, S. (2025). Concomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: Real-world data from the ARON-2EV study. Clinical & experimental metastasis, 42(2), 18. https://doi.org/10.1007/s10585-025-10335-4

Chicago Style (17th ed.) Citation

O, Fiala, et al. "Concomitant Medications in Patients with Metastatic Urothelial Carcinoma Receiving Enfortumab Vedotin: Real-world Data from the ARON-2EV Study." Clinical & Experimental Metastasis 42, no. 2 (2025): 18. https://doi.org/10.1007/s10585-025-10335-4.

MLA (9th ed.) Citation

O, Fiala, et al. "Concomitant Medications in Patients with Metastatic Urothelial Carcinoma Receiving Enfortumab Vedotin: Real-world Data from the ARON-2EV Study." Clinical & Experimental Metastasis, vol. 42, no. 2, 2025, p. 18, https://doi.org/10.1007/s10585-025-10335-4.